Concentra Group Net Income From Continuing Ops Over Time
| CON Stock | 22.81 0.66 2.98% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Concentra Group Performance and Concentra Group Correlation. Concentra | Build AI portfolio with Concentra Stock |
Will Health Care Providers & Services sector continue expanding? Could Concentra diversify its offerings? Factors like these will boost the valuation of Concentra Group. Projected growth potential of Concentra fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concentra Group data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.026 | Dividend Share 0.25 | Earnings Share 1.17 | Revenue Per Share | Quarterly Revenue Growth 0.17 |
Investors evaluate Concentra Group Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Concentra Group's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Concentra Group's market price to deviate significantly from intrinsic value.
It's important to distinguish between Concentra Group's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concentra Group should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Concentra Group's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income From Continuing Ops Analysis
Compare Concentra Group Holdings and related stocks such as Haemonetics, Dentsply Sirona, and Bausch Health Companies Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE | 80 M | 66.9 M | 38.8 M | 35.1 M | 16.9 M | (55.6 M) | (26.3 M) | 45.6 M | 55 M | 76.5 M | 79.5 M | 43.4 M | 115.4 M | 117.6 M | 167.7 M | 192.8 M | 202.5 M |
| XRAY | 274.4 M | 245.1 M | 321.8 M | 317.2 M | 323.3 M | 252.7 M | 431.4 M | (1.6 B) | (1 B) | 263.1 M | (83 M) | 421 M | (950 M) | (132 M) | (910 M) | (819 M) | (778 M) |
| BHC | (208.2 M) | 159.6 M | (116 M) | (863.7 M) | 912.2 M | (287.8 M) | (2.4 B) | 2.4 B | (4.1 B) | (1.8 B) | (559 M) | (937 M) | (212 M) | (611 M) | (72 M) | (64.8 M) | (68 M) |
| CPRX | (6.4 M) | (6.4 M) | (4.1 M) | (12.2 M) | (15.5 M) | (20.2 M) | (18.1 M) | (18.4 M) | (34 M) | 31.9 M | 75 M | 39.5 M | 83.1 M | 62 M | 163.9 M | 188.5 M | 197.9 M |
| PINC | 332.6 M | 332.6 M | 332.6 M | 332.6 M | 234.8 M | 235.2 M | 449.5 M | 257.6 M | 334.7 M | 291.1 M | 304.6 M | 268.3 M | 174.9 M | 106.7 M | 72.7 M | 65.5 M | 62.2 M |
| ITGR | 33.1 M | 33.1 M | (4.8 M) | 36.5 M | 55.1 M | (7.6 M) | 5.4 M | 66.8 M | 47 M | 91.2 M | 77.3 M | 93 M | 65.3 M | 90.7 M | 121.1 M | 139.2 M | 146.2 M |
| HCM | 26.9 M | 26.9 M | 26.9 M | 26.9 M | (6.1 M) | 10.4 M | 14.6 M | (23 M) | (71.3 M) | (103.7 M) | (115.5 M) | (167 M) | (360.4 M) | 101.1 M | 38.2 M | 34.4 M | 36.1 M |
| BEAM | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (116.7 M) | (78.3 M) | (194.6 M) | (370.6 M) | (289.1 M) | (313.7 M) | (376.7 M) | (339.1 M) | (356 M) |
| PBH | 37.2 M | 37.2 M | 65.5 M | 72.6 M | 78.3 M | 99.9 M | 69.4 M | 339.6 M | (35.8 M) | 142.3 M | 164.7 M | 205.4 M | (82.3 M) | 209.3 M | 214.6 M | 246.8 M | 124.2 M |
| ADUS | (2 M) | (2 M) | 9.3 M | 11.2 M | 12 M | 11.4 M | 11.9 M | 13.5 M | 17.4 M | 25.8 M | 33.1 M | 45.1 M | 46 M | 57.7 M | 73.6 M | 84.6 M | 88.9 M |
Concentra Group Holdings and related stocks such as Haemonetics, Dentsply Sirona, and Bausch Health Companies Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Concentra Group Holdings | CON |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 5080 Spectrum Drive, |
| Exchange | New York Stock Exchange |
null 22.81
Check out Concentra Group Performance and Concentra Group Correlation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Concentra Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.